Synopsis
I believe we are at a turning point where vast amounts of biological data can be translated to clinical care with the use of simple and affordable technology. We aim to broaden our under understanding of critical cancer pathways and translate our findings to cancer care. Our projects bind novel computational approaches with an extensive clinical database lead to a deeper understanding of biological pathways and to an inclusive approach to risk assessment that will better serve cancer prevention and cancer care.